ArticleBMC psychology2026
Effectiveness of multi-family group therapy for school refusal in adolescents with depressive disorders: study protocol for a randomized controlled trial.
Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study aims to develop a manualized multi-family group therapy (MFGT) program for adolescents with depressive school refusal and to evaluate its effectiveness through a randomized controlled trial. By comparing MFGT with group cognitive behavioral therapy (GCBT), the study seeks to examine the relative efficacy of MFGT in improving school refusal behaviors and depressive symptoms, to assess the stability of treatment effects during follow-up, and to explore potential mechanisms underlying behavioral change.
methodsThis study is designed as a single-center, single-blind, randomized controlled non-inferiority trial. A total of 138 adolescents aged 12-19 years who meet DSM-5 criteria for depressive disorders and Berg’s criteria for school refusal will be randomly assigned in a 1:1 ratio to either the MFGT plus treatment-as-usual (TAU) group or the GCBT plus TAU group. Both interventions consist of eight group sessions delivered over four weeks. Primary outcomes include school attendance rate and clinician-rated depressive symptoms assessed using the Hamilton Depression Rating Scale. Secondary and intermediate outcomes include self-reported depressive and anxiety symptoms, school refusal maintaining factors, school-related self-efficacy, family functioning, and parent–adolescent communication. Assessments will be conducted at baseline, post-treatment, and at 1- and 3-month follow-up. DISCUSSION: This study will be the first randomized controlled trial to evaluate a standardized and manualized MFGT protocol specifically developed for adolescents with depressive school refusal. By adopting a family-based and scalable intervention model, the study is expected to provide evidence for an effective and resource-efficient treatment approach that addresses both individual psychopathology and family dynamics. The findings may contribute to improving school attendance and mental health outcomes in adolescents and inform clinical practice and public mental health strategies in settings with limited mental health resources.
trial registrationChinese Clinical Trial Registry (ChiCTR2500100225). Registered, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.